# BRAFTOVI

NDC: 70255-025
Generic name: Encorafenib
Labeler / Manufacturer: Array BioPharma Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20180627

FDA application: NDA210496

## Active ingredients

- ENCORAFENIB: 75 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70255-025"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70255-025
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=235dfc38-0f0b-4037-b501-7a9f4294740c